Which is more profitable, Merck & or Pfizer?

Merck & keeps more of every sale as profit.

Which grows faster, Merck & or Pfizer?

Merck & grew its sales faster in recent years.

Which is cheaper, Merck & or Pfizer?

Merck & costs less for each unit of yearly profit (lower P/E).

Which has less debt, Merck & or Pfizer?

Merck & would need fewer years of earnings to pay off its debt.

Merck &MRKvs

PfizerPFE

Merck & vs Pfizer stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Merck & is more profitable, grows faster, is cheaper for its profits and has less debt.

Side by side

	Merck &	Pfizer
	$364 billion	$165 billion
	28.1%	12.4%
	+9.4%	+8.5%
	20.0×	21.2×
	1.2 years	3.7 years
	17.8%	5.5%
	2.8%	6.6%

Open Merck &Open Pfizer

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Merck & vs Regeneron Pharmaceuticals · Merck & vs Roche · Merck & vs Sanofi · Merck & vs Stryker · Pfizer vs Roche · Pfizer vs UnitedHealth · Pfizer vs AbbVie · Pfizer vs Johnson & Johnson